Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGXNYSE:DVANYSE:LHNASDAQ:RCM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$179.32-0.2%$176.12$136.30▼$182.38$20.02B0.49993,035 shs651,399 shsDVADaVita$146.77+3.0%$139.64$131.76▼$179.60$11.08B1.11807,947 shs878,187 shsLHLabcorp$263.96+0.6%$249.18$198.96▼$265.72$22.09B0.81640,083 shs617,873 shsRCMR1 RCM$14.31$14.28$10.58▼$14.32$6.04B0.844.24 million shsN/A10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics+1.01%-0.12%+3.73%+5.95%+31.15%DVADaVita+0.49%+4.44%+4.64%-6.21%+2.76%LHLabcorp+0.80%+0.53%+5.54%+12.79%+28.93%RCMR1 RCM0.00%0.00%0.00%0.00%+13.93%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGXQuest Diagnostics4.9426 of 5 stars2.34.04.24.73.42.52.5DVADaVita4.2091 of 5 stars2.01.00.04.52.21.73.8LHLabcorp4.444 of 5 stars2.42.02.54.23.42.51.3RCMR1 RCM1.1038 of 5 stars1.10.00.03.60.03.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.69Moderate Buy$185.733.66% UpsideDVADaVita 2.00Hold$164.5012.45% UpsideLHLabcorp 2.79Moderate Buy$276.084.46% UpsideRCMR1 RCM 2.18Hold$15.407.62% UpsideCurrent Analyst Ratings BreakdownLatest RCM, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingCautious ➝ Cautious6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.006/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/19/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$170.00 ➝ $164.005/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.005/6/2025LHLabcorpPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.005/6/2025DGXQuest DiagnosticsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $190.004/30/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$240.00 ➝ $250.004/30/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$253.00 ➝ $267.004/28/2025DGXQuest DiagnosticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.004/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$182.00 ➝ $190.00(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$9.87B2.03$13.60 per share13.17$61.38 per share2.92DVADaVita$12.82B0.86$19.77 per share7.40$4.83 per share30.29LHLabcorp$13.01B1.70$22.72 per share11.63$96.27 per share2.75RCMR1 RCM$2.25B2.68$0.69 per share20.89$6.66 per share2.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$7.9122.6217.082.488.81%15.11%6.65%7/22/2025 (Estimated)DVADaVita$936.34M$10.0914.4711.510.986.63%176.11%4.66%8/5/2025 (Estimated)LHLabcorp$746M$8.6530.5215.071.655.55%15.27%6.97%7/30/2025 (Estimated)RCMR1 RCM$3.30M-$0.15N/A71.55N/A-2.48%-2.18%-1.10%N/ALatest RCM, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025DGXQuest Diagnostics$2.56N/AN/AN/A$2.73 billionN/A5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.79%N/A40.46%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.09%N/A33.29%N/ARCMR1 RCMN/AN/AN/AN/AN/ALatest RCM, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20254/10/2025LHLabcorpquarterly$0.721.25%5/29/20256/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.841.441.31DVADaVita23.181.251.20LHLabcorp0.681.841.60RCMR1 RCM0.761.791.79Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%RCMR1 RCM61.10%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%DVADaVita2.00%LHLabcorp0.84%RCMR1 RCM36.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableDVADaVita70,00075.50 million73.99 millionOptionableLHLabcorp70,00083.70 million83.00 millionOptionableRCMR1 RCM30,000422.39 million266.95 millionOptionableRCM, LH, DGX, and DVA HeadlinesRecent News About These CompaniesR1 Appoints Dave Wojczynski as President to Lead Physician Revenue Cycle Management BusinessJune 18, 2025 | finance.yahoo.comFormer Revecore CEO joins R1 RCMJune 18, 2025 | beckershospitalreview.comB'Order the New Mountain special': How one private equity firm is bringing big exits back to healthcare VCJune 16, 2025 | businessinsider.comR1 RCM names two executivesJune 12, 2025 | beckershospitalreview.comBR1 Expands Finance and Corporate Development Teams with New AppointmentsJune 11, 2025 | finance.yahoo.comTech company widens South Bay buying binge with new property dealJune 2, 2025 | eastbaytimes.comE8 RCM headlines to know from MayJune 2, 2025 | beckershospitalreview.comBCybersecurity firm continues real estate growth, buys Sunnyvale building at a discountJune 2, 2025 | bizjournals.comFierce Healthcare Fundraising Tracker —Zeal Capital Partners collects $82M; R1 secures investment from Khosla VenturesJune 2, 2025 | fiercehealthcare.comFBig tech company widens South Bay buying binge with new property dealJune 2, 2025 | mercurynews.comMR1 RCM secures investment to boost AI effortsMay 28, 2025 | beckershospitalreview.comBR1 Announces Investment from Khosla Ventures as it Accelerates AI-Driven Healthcare TransformationMay 28, 2025 | finance.yahoo.com3 RCM companies combineMay 20, 2025 | beckershospitalreview.comBBlack Book Research: Robotic Process Automation Transforms Healthcare RCM: 2025 Survey Highlights From Black BookApril 25, 2025 | finanznachrichten.de9 Under-the-Radar AI Innovations Set to Transform Healthcare Revenue Cycle Management- Black Book ResearchApril 21, 2025 | finance.yahoo.comMeet the two twenty-somethings running Palantir's healthcare AI businessApril 3, 2025 | businessinsider.comHealthcare Revenue Cycle Management Market is Expected to Reach ~11–12% CAGR by 2027March 31, 2025 | pharmiweb.comPThe U.S. Revenue Cycle Management Market Surges to $272.78 Billion by 2030, Multi-Billion Opportunity Projected in the Coming Years – AriztonMarch 27, 2025 | theglobeandmail.comCould Palantir's R1 Deal Be the Catalyst for a Stock Surge?March 21, 2025 | msn.comR1 And Palantir Launch AI Lab To Transform Healthcare Revenue ManagementMarch 16, 2025 | nasdaq.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRCM, LH, DGX, and DVA Company DescriptionsQuest Diagnostics NYSE:DGX$179.32 -0.32 (-0.18%) Closing price 03:59 PM EasternExtended Trading$177.64 -1.68 (-0.94%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$146.77 +4.32 (+3.03%) Closing price 03:59 PM EasternExtended Trading$146.76 -0.01 (-0.01%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$263.96 +1.45 (+0.55%) Closing price 03:59 PM EasternExtended Trading$264.26 +0.29 (+0.11%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.R1 RCM NASDAQ:RCMR1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
